Skip to main content
. 2018 Oct 10;13(10):e0204477. doi: 10.1371/journal.pone.0204477

Fig 7. Plasmablasts analysis following HBV.

Fig 7

(a-b). Representative FACS analysis for plasmablast enumeration (a) and isotyping (b) before and 7 days after recombinant hepatitis B surface antigen vaccination. (c). Plasmablast responses for total and isotyped PB. (d). Total and IgG plasmablast responses according to HBV dose schedule (20mcg or 40mcg schedule) in CKD patients. HC, healthy controls (blue), n = 10; CKD, chronic kidney disease patients (black), n = 21; PB, plasmablasts; Δ = change in PB (day 7 minus PB at baseline, when expressed as a percentage of total B cells).